Martyn T, Saef J, Bansal A, Martinez KA, et al. Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2i) Following FDA Approval for Heart Failure with Preserved and Mildly Reduced Ejection Fraction. J Card Fail 2024 Feb 15:S1071-9164(24)00035.
PMID: 38367905